3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
8
Ganglioneuroblastoma
4
Triple Negative Breast Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Adenoma, Islet Cell
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Resectable Esophageal Cancer
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Merkel Cell
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Interventions
venetoclax
69
Cyclophosphamide
53
ibrutinib
44
obinutuzumab
43
acalabrutinib
42
Rituximab
40
fludarabine
37
fludarabine phosphate
30
Specimen Handling
29
pirtobrutinib
25
Biopsy
24
zanubrutinib
23
Whole-Body Irradiation
16
Bendamustine Hydrochloride
15
Magnetic Resonance Spectroscopy
14
Mycophenolic Acid
13
Lenalidomide
11
Peripheral Blood Stem Cell Transplantation
9
Sirolimus
8
idelalisib
7
Tacrolimus
7
CT-P10
7
ARQ531
7
tafasitamab
6
Prednisone
6
Busulfan
6
pembrolizumab
5
Stem Cell Transplantation
5
Melphalan
5
Interleukin-2
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphocytic, Chronic, B-Cell
×
Colony-Stimulating Factors
×
1 year
×
Clear all
No trials found.